The University of Chicago Header Logo

Connection

Everett E. Vokes to Fallopian Tube Neoplasms

This is a "connection" page, showing publications Everett E. Vokes has written about Fallopian Tube Neoplasms.
Connection Strength

0.080
  1. Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. Gynecol Oncol. 2008 Jul; 110(1):49-55.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.